Ryan Freeland, MD
Dermatology · Wyoming, MINPI 1942265178
Payments from drug & device makers
Across 171 payments — averaging $58.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofrontera Inc.$6K
- AbbVie$602
- Novartis$371
- Sanofi$321
- Regeneron Healthcare Solutions, Inc.$232
- E.r. Squibb & Sons, L.L.C.$220
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,61636%
- Other$6,40164%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofrontera Inc. | 4 | $6,447 |
| AbbVie | 26 | $602 |
| Novartis | 18 | $371 |
| Sanofi | 14 | $321 |
| Regeneron Healthcare Solutions, Inc. | 9 | $232 |
| E.r. Squibb & Sons, L.L.C. | 12 | $220 |
| Amgen | 8 | $204 |
| Lilly USA, LLC | 9 | $186 |
| Sun Pharmaceutical Industries Inc. | 6 | $135 |
| Johnson & Johnson | 6 | $133 |
| Arcutis Biotherapeutics, Inc. | 6 | $124 |
| Boehringer Ingelheim | 6 | $120 |
| UCB, Inc. | 5 | $119 |
| LEO Pharma Inc. | 5 | $103 |
| Incyte Corporation | 5 | $101 |
| Organon | 4 | $88 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $75 |
| Galderma Laboratories, L.p. | 4 | $74 |
| Pfizer | 3 | $63 |
| DUSA Pharmaceuticals, Inc. | 2 | $39 |
| Sandoz | 2 | $34 |
| Dermavant Sciences, Inc. | 2 | $32 |
| Journey Medical Corporation | 2 | $29 |
| Almirall LLC | 2 | $28 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Kerecis Limited | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| LNHC, Inc | 1 | $14 |
| Botanix SB Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$6,401
- BF-RhodoLED$6,401
- XEPI$6,401
How this compares
$10,017 in reported general payments places this provider in the 80th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 25 | $204,483 |
| Taltz AutoinjectorIxekizumab | 11 | $70,291 |
| Fluorouracil | 99 | $5,678 |
| Clobetasol Propionate | 226 | $4,977 |
| Clotrimazole | 191 | $2,813 |
| Ketoconazole | 209 | $2,730 |
| Mycophenolate Mofetil | 14 | $2,519 |
| Triamcinolone Acetonide | 211 | $2,492 |
| Tretinoin | 21 | $1,533 |
| Metronidazole | 31 | $1,329 |
| MethotrexateMethotrexate Sodium | 42 | $1,251 |
| Doxycycline Monohydrate | 42 | $1,183 |
| Minocycline Hcl | 29 | $1,135 |
| Hydroxychloroquine Sulfate | 13 | $1,011 |
| Imiquimod | 18 | $405 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wyoming
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
- Mio NakamuraAnn Arbor$1.4M
- George MurakawaTroy$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.